Future Clinical Trials: Sequencing Decisions for Bispecifics and CAR T-Cell Therapy
Shaji Kumar, MD, reviews data from cohort C of CARTITUDE-2 and a real-world study evaluating ide-cel in patients with relapsed/refractory multiple myeloma.
EP: 1.Clinical Scenario 1: A 67-Year-Old Man with Multiple Myeloma
EP: 2.Treatment Options in Late-line R/R MM Patients
EP: 3.Sequencing Options of Bispecifics in R/R MM
EP: 4.Pooled Analysis from MagnetisMM Studies
EP: 5.Consideration in Treatment Selection and Sequencing in R/R MM
EP: 6.Clinical Scenario 2: A 70-Year-Old Male with R/R MM
EP: 7.Treatment Options for Late-line R/R MM
EP: 8.Overview of CAR-T Sequencing Strategies in R/R MM
EP: 9.Challenges in Optimizing Sequencing
Now Viewing
EP: 10.Future Clinical Trials: Sequencing Decisions for Bispecifics and CAR T-Cell Therapy
Recent Videos
Related Content
